Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients

Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Brachytherapy - Volume 12, Issue 5, September–October 2013, Pages 389-392

Daniel E. Spratt, Michael J. Zelefsky,